- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£225.5b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£144.56
7D
1.0%
1Y
39.9%
Gilead Sciences
Market Cap: US$163.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$131.27
7D
2.7%
1Y
17.5%
Chugai Pharmaceutical
Market Cap: JP¥12.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,642.00
7D
2.8%
1Y
7.3%
Orion Oyj
Market Cap: €10.2b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€72.00
7D
2.9%
1Y
14.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥58.9b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥130.88
7D
40.0%
1Y
38.3%
Xiamen Amoytop Biotech
Market Cap: CN¥23.9b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥58.50
7D
10.5%
1Y
-18.6%
PharmaResearch
Market Cap: ₩3.5t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩341,000.00
7D
5.2%
1Y
-30.8%